There was consensus that prostate cancer screening advice for males with a GPV in ATM or CHEK2 should be given at the time of diagnosis, including advice to seek a reassessment if there were any further cancer diagnoses in the family or if they have specific questions about their genetic diagnosis. This evidence concerns the gene CHEK2 and prostate cancer.